Filing Details
- Accession Number:
- 0001209191-18-042903
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-17 18:30:29
- Reporting Period:
- 2018-07-13
- Accepted Time:
- 2018-07-17 18:30:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406338 | Amit Sachdev | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cro | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-07-13 | 12,031 | $96.87 | 58,693 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-13 | 12,031 | $180.00 | 46,662 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-07-16 | 1,719 | $96.87 | 48,381 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-16 | 1,500 | $180.14 | 46,881 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-07-16 | 219 | $181.88 | 46,662 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-07-13 | 12,031 | $0.00 | 12,031 | $96.87 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-07-16 | 1,719 | $0.00 | 1,719 | $96.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,719 | 2024-07-14 | No | 4 | M | Direct | |
| 0 | 2024-07-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 882 | Indirect | 401(k) |
| Common Stock | 12,215 | Indirect | Held in Trust |
Footnotes
- Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $180.14 (range $180.00 - $180.66).
- Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $181.88 (range $181.65 - $181.93).
- Fully vested.
Billionaire Hedge Funds
